Compare Citius Pharmaceuticals Inc (CTXR) vs CubeSmart (CUBE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs CubeSmart — how do they compare? Citius Pharmaceuticals Inc trades at $0.52 (market cap $14.83M), while CubeSmart trades at $40.56 (market cap $9.19B). The key difference: CubeSmart is far larger — about 619.7× Citius Pharmaceuticals Inc's market cap, and CubeSmart pays a 5.22% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CTXR | CUBE | |
|---|---|---|
Market Cap | $14.83M | $9.19B |
Sector | Health | Real Estate |
52-Week High | $1.82 | $42.34 |
52-Week Low | $0.53 | $35.36 |
Enterprise Value | $11.05M | $12.69B |
Dividend Yield | — | 5.22% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About CubeSmart
CubeSmart is a real estate investment trust that acquires, owns, and manages self-storage facilities throughout the United States. The company's real estate portfolio is composed of buildings with numerous enclosed storage areas for both residential and commercial customers to rent mainly on a month-by-month basis. Most of CubeSmart's facilities are located in Florida, Texas, California, New York, and Illinois. Cumulatively, these states account for both the majority of the square footage in the company's real estate portfolio and the majority of its revenue. CubeSmart derives nearly all of its revenue from rental income from tenants utilizing its storage facilities.
Read more on CUBE →
